Thalamic and cerebellar gray matter volume reduction in synthetic cannabinoids users

European Addiction Research

Volumn 21, Issue 6, 2015, Pages 315-320

  Nurmedov, Serdar ^a   Metin, Baris ^b   Ekmen, Sehadet ^b   Noyan, Onur ^a   Yilmaz, Onat ^c   Darcin, Asli ^d   Dilbaz, Nesrin ^b  

^a NPIstanbul Neuropsychiatry Hospital   (Turkey)

^b USKUDAR UNIVERSITY   (Turkey)

^c KASIMPASA MILITARY HOSPITAL   (Turkey)

^d Kanuni Sultan Suleyman Public Hospital   (Turkey)

Author keywords

Addiction; Cerebellum; Gray matter; Neuroimaging; Synthetic cannabinoids; Synthetic drugs; Thalamus; Volumetric magnetic resonance imaging

Indexed keywords

CANNABINOID; CANNABIS; SYNTHETIC CANNABINOID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN REGION; BRAIN SIZE; BRAIN TISSUE; CANNABIS USE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; GRAY MATTER; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; THALAMUS; URINALYSIS; VOXEL BASED MORPHOMETRY; CANNABIS ADDICTION; CASE CONTROL STUDY; COMPLICATION; DRUG EFFECTS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; YOUNG ADULT;

ADULT; CANNABINOIDS; CASE-CONTROL STUDIES; CEREBELLUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MARIJUANA ABUSE; NEUROIMAGING; THALAMUS; YOUNG ADULT;

EID: 84930260047     PISSN: 10226877     EISSN: 14219891     Source Type: Journal    
DOI: 10.1159/000430437     Document Type: Article

References (18)

1. Ameri A: The effects of cannabinoids on the brain. Prog Neurobiol 1999; 58: 315-348
2. Evren C, Bozkurt M: Sentetik Kannabinoidler: Son Yillarin Krizi. Düşünen Adam The Journal of Psychiatry and Neurological Sciences 2013; 26: 1-11
3. Asbridge M, Duff C, Marsh DC, Erickson PG: Problems with the identification of 'problematic' cannabis use: examining the issues of frequency, quantity, and drug use environment. Eur Addict Res 2014; 20: 254-267
4. Presley BC, Jansen-Varnum SA, Logan BK: Analysis of synthetic cannabinoids in botanical material: a review of analytical methods and findings. Forensic Sci Rev 2013; 25: 27
5. Showalter VM, Compton DR, Martin BR, Abood ME: Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 1996; 278: 989-999
6. Wintermeyer A, Möller I, Thevis M, Jübner M, Beike J, Rothschild MA, Bender K: In vitro phase I metabolism of the synthetic cannabimimetic JWH-018. Anal Bioanal Chem 2010; 398: 2141-2153
7. Block RI, O'Leary DS, Ehrhardt JC, Augustinack JC, Ghoneim MM: Effects of frequent marijuana use on brain tissue volume and composition. Neuroreport 2000; 11: 491-496
8. DeLisi LE, Bertisch HC, Szulc KU, Majcher M, Brown K: A preliminary DTI study showing no brain structural change associated with adolescent cannabis use. Harm Reduct J 2006; 3: 17
9. Cousijn J, Wiers RW, Ridderinkhof KR, Van Den Brink W, Veltman DJ, Goudriaan AE: Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. Neuroimage 2012; 59: 3845-3851
10. Matochik JA, Eldreth DA, Cadet JL, Bolla KI: Altered brain tissue composition in heavy marijuana users. Drug Alcohol Depend 2005; 77: 23-30
11. Lorenzetti V, Solowij N, Whittle S, Fornito A, Lubman DI, Pantelis C, Yücel M: Gross morphological brain changes with chronic, heavy cannabis use. Br J Psychiatry 2015; 206: 77-78
12. Demirakca T, Sartorius A, Ende G, Meyer N, Welzel H, Skopp G, Mann K, Hermann D: Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol. Drug Alcohol Depend 2011; 114: 242-245
13. Ashburner J, Friston KJ: Voxel-based morphometry-the methods. Neuroimage 2000; 11: 805-821
14. Papanti D, Schifano F, Botteon G, Bertossi F, Mannix J, Vidoni D, Impagnatiello M, Pascolo-Fabrici E, Bonavigo T: 'Spiceophrenia': a systematic overview of 'spice'-related psychopathological issues and a case report. Hum Psychopharmacol 2013; 28: 379-389
15. Byne W, Hazlett EA, Buchsbaum MS, Kemether E: The thalamus and schizophrenia: current status of research. Acta Neuropathol 2009; 117: 347-368
16. Ashton JC, Appleton I, Darlington CL, Smith PF: Immunohistochemical localization of cannabinoid CB1 receptor in inhibitory interneurons in the cerebellum. Cerebellum 2004; 3: 222-226
17. Solowij N, Stephens RS, Roffman RA, Babor T, Kadden R, et al: Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 2002; 287: 1123-1131
18. Solowij N, Yücel M, Respondek C, Whittle S, Lindsay E, et al: Cerebellar white-matter changes in cannabis users with and without schizophrenia. Psychol Med 2011; 41: 2349-2359